PharmaShell’s layers are built atom-by-atom. [Illustration courtesy of Nanexa] Novo (NYSE: NVO) has tapped the Swedish drug-delivery developer Nanexa to develop long-acting injectable platforms for ...
The Lingo over-the-counter CGM [Image courtesy of Abbott] Abbott (NYSE: ABT) is teaming up with Berry Street to offer dietitian support programs to Lingo users. Wearers of the over-the-counter ...
The Mint patch pump system [Image courtesy of Beta Bionics] Beta Bionics (NASDAQ: BBNX) has claimed an FDA clearance for its first patch pump insulin delivery system, amid plans to roll out an updated ...
The Furoscix ReadyFlow auto-injector [Image courtesy of MannKind] MannKind (Nasdaq:MNKD) announced today that it secured $50 million in a private placement and earned a new regulatory nod. In addition ...
A woman wears the Stelo OTC CGM [Image courtesy of Dexcom] The FDA announced today that it selected Dexcom (Nasdaq:DXCM) as the first manufacturer for a new digital health pilot. Dexcom joins the ...
Insulet (Nasdaq:PODD) announced today that it has partnered with Calm, a leading consumer mental health company. The companies say they are coming together to provide emotional well-being resources ...
The components of the CGM+ system. [Image courtesy of Trinity Biotech] Trinity Biotech (Nasdaq:TRIB) today announced new clinical findings supporting its next-generation continuous glucose monitor ...
The FiberSense sensor works to continuously monitor glucose. [Image courtesy of the company] FiberSense announced today that it received CE mark approval for its continuous glucose monitoring (CGM) ...
The Eversense 365 CGM. [Image courtesy of Senseonics] Senseonics (NYSE:SENS) and Welldoc today announced a strategic partnership to develop a new custom mobile application for Eversense 365. Eversense ...
The biggest names in diabetes tech gathered in New Orleans last weekend for the American Diabetes Association’s 86th Scientific Sessions (ADA 2026). Clinical findings supporting next-generation ...
The 15-day G7 CGM in use. [Image courtesy of Dexcom] Nearly halfway through 2026, the milestones are already stacking up for continuous glucose monitor (CGM) maker Dexcom (Nadsaq:DXCM). Finally, last ...
Terrestrial Bio today shared new preclinical data demonstrating the translatability of its patch technology for delivering GLP-1 therapies. Boston-based Terrestrial (formerly Vaxess Technologies) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results